These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer. Schwen ZR; Gupta M; Pierorazio PM Adv Urol; 2018; 2018():2146080. PubMed ID: 29853869 [TBL] [Abstract][Full Text] [Related]
7. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors. Abdel-Aziz KF; Anderson JK; Svatek R; Margulis V; Sagalowsky AI; Cadeddu JA J Endourol; 2006 Sep; 20(9):627-31. PubMed ID: 16999613 [TBL] [Abstract][Full Text] [Related]
8. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis. Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573 [TBL] [Abstract][Full Text] [Related]
9. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704 [TBL] [Abstract][Full Text] [Related]
10. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis]. Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511 [No Abstract] [Full Text] [Related]
11. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. Cheney SM; Andrews PE; Leibovich BC; Castle EP BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience. Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review. Haarsma R; Blok JM; van Putten K; Meijer RP Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176 [TBL] [Abstract][Full Text] [Related]
14. Post-chemotherapy robotic retroperitoneal lymph node dissection (RRPLND) in testicular cancer. Kamel MH; Jackson CM; Moore JT; Heshmat SM; Bissada NK J Robot Surg; 2012 Dec; 6(4):359-62. PubMed ID: 27628479 [TBL] [Abstract][Full Text] [Related]
15. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)]. Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R Urologia; 2010; 77(2):84-7. PubMed ID: 20890864 [TBL] [Abstract][Full Text] [Related]
16. Robot-assisted supine extraperitoneal retroperitoneal lymph node dissection: a novel approach for template dissection in post-chemotherapy residual mass in non-seminomatous germ cell tumours. Pooleri GK; Bijalwan P; Kesavan R; Philip A; Keechilat P J Robot Surg; 2019 Feb; 13(1):171-173. PubMed ID: 29728822 [TBL] [Abstract][Full Text] [Related]
17. [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity]. Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C Urologe A; 2013 Aug; 52(8):1097-103. PubMed ID: 23416965 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center. Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782 [TBL] [Abstract][Full Text] [Related]
19. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Nelson JB; Chen RN; Bishoff JT; Oh WK; Kantoff PW; Donehower RC; Kavoussi LR Urology; 1999 Dec; 54(6):1064-7. PubMed ID: 10604709 [TBL] [Abstract][Full Text] [Related]
20. Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle. Ghandour R; Ashbrook C; Freifeld Y; Singla N; El-Asmar JM; Lotan Y; Margulis V; Eggener S; Woldu S; Bagrodia A Eur Urol Oncol; 2020 Apr; 3(2):198-206. PubMed ID: 31272940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]